Evernow review
Evernow places GLP-1 assessment within menopause-focused care, with membership or individual visits. Medication costs and suitability remain separate from access to the care team.
The verdict
Evernow’s distinction is context: weight concerns can be discussed alongside perimenopause and menopause symptoms. That does not mean a GLP-1 or hormone treatment is necessary for every patient. The useful question is how the provider evaluates the whole picture without turning access to a broad menu into a preset treatment plan.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- Prescription
- Required
The platform offers menopause, hormone and weight-related care. Its treatment menu names Ozempic, Wegovy, Zepbound and Mounjaro. These products have different labeled uses; the presence of a brand in a menu does not establish suitability for every midlife weight concern.
Who writes the prescription, and what do they see?
Care is provided by a matched professional, while the platform terms distinguish Evernow from the medical provider. The service advertises matching within 24 hours. That is an access statement, not a guarantee of a prescription, insurance approval or a particular clinician assignment.
Patients can choose pay-per-visit access or ongoing membership. Membership describes secure messaging, prescription access, automated refills and optional insurance-covered video visits. Clarify what is covered by the selected arrangement and how medical concerns reach the provider between scheduled contacts.
What happens when the dose goes up?
Personalized care plans may include a GLP-1 when clinically appropriate. Ask how follow-up, tolerance assessment and refill authorization are handled for that medicine. Automated refill functionality should not be confused with automatic clinical approval for an increased dose.
What the price includes
Membership starts at $35 per month, and the site also offers individual video visits. This is a care-access figure, not a medicine-inclusive drug price. Insurance acceptance for certain video visits does not establish coverage for a weight-loss prescription.
What it claims, and what it cites
The public menu names approved semaglutide and tirzepatide brands. Medications can be sent to a pharmacy or delivered according to the plan. Confirm the actual product and indication with the prescriber, especially when coordinating weight treatment with hormone therapy or other existing medicines.
Where it holds up, and where it does not
- Strength: Menopause-related concerns can be considered together
- Strength: Membership and individual visits are separate options
- Strength: Messaging and refill functions are described
- Limitation: Care price does not establish medication cost
- Limitation: Insurance depends on the service and plan
- Limitation: Provider matching does not guarantee treatment
What the evidence says about this kind of treatment
The assessment above is about Evernow. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A patient seeking menopause-informed clinical discussion of weight concerns and other midlife symptoms.
- Wrong for
- Someone seeking a guaranteed GLP-1 prescription or assuming membership includes the medicine.
The evidence behind what Evernow prescribes
These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.
- Cochrane Review of Semaglutide for Obesity: 18 Trials Graded
A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower.
- Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?
In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points.
How Evernow compares
| Seller | Who it suits | Go |
|---|---|---|
| SkinnyRx | Readers choosing tirzepatide, the one line with a published standing rate | See SkinnyRx → |
| ShedRx | Readers willing to telephone a seller and ask which published fee is the real one | See ShedRx → |
| RxSpan MD | Buyers who want the standing rate, the pharmacy and the prescriber named before signing up | See RxSpan MD → |
More GLP-1 telehealth sellers reviews: Lyfe RxMadeMedMANÜ TelehealthMarek HealthMavesMaximus
Sponsored alternative
SkinnyRx
Readers choosing tirzepatide, the one line with a published standing rate
Check SkinnyRx availability →Frequently asked
- Is GLP-1 treatment available within the care plan?
- Evernow includes GLP-1s among possible personalized treatments and lists approved brand options; the provider still determines appropriateness.
- Does membership pay for the drug?
- The starting membership figure describes care access. Medication price and coverage must be established separately.
- Must every patient subscribe?
- The current service description also offers individual pay-per-visit video care.
Sources for this review
Provider information checked . Terms can change.